ATE299497T1 - Zur behandlung von autoimmunerkrankungen und allergien geeignete sulfonderivate - Google Patents
Zur behandlung von autoimmunerkrankungen und allergien geeignete sulfonderivateInfo
- Publication number
- ATE299497T1 ATE299497T1 AT02790435T AT02790435T ATE299497T1 AT E299497 T1 ATE299497 T1 AT E299497T1 AT 02790435 T AT02790435 T AT 02790435T AT 02790435 T AT02790435 T AT 02790435T AT E299497 T1 ATE299497 T1 AT E299497T1
- Authority
- AT
- Austria
- Prior art keywords
- allergies
- treatment
- autoimmune diseases
- derivatives suitable
- sulfone derivatives
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 150000003457 sulfones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0128376.1A GB0128376D0 (en) | 2001-11-27 | 2001-11-27 | Novel compounds |
| PCT/EP2002/013263 WO2003045922A1 (en) | 2001-11-27 | 2002-11-25 | Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE299497T1 true ATE299497T1 (de) | 2005-07-15 |
Family
ID=9926523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02790435T ATE299497T1 (de) | 2001-11-27 | 2002-11-25 | Zur behandlung von autoimmunerkrankungen und allergien geeignete sulfonderivate |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7038055B2 (enExample) |
| EP (1) | EP1448529B1 (enExample) |
| JP (1) | JP2005513034A (enExample) |
| AR (1) | AR037426A1 (enExample) |
| AT (1) | ATE299497T1 (enExample) |
| AU (1) | AU2002365510A1 (enExample) |
| DE (1) | DE60205035T2 (enExample) |
| ES (1) | ES2243783T3 (enExample) |
| GB (1) | GB0128376D0 (enExample) |
| TW (1) | TW200303746A (enExample) |
| WO (1) | WO2003045922A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706255D0 (en) * | 1997-03-26 | 1997-05-14 | Smithkline Beecham Plc | Novel compounds |
| DK1001930T3 (da) * | 1997-07-31 | 2003-03-24 | Abbott Lab | N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser |
| DE69934094T2 (de) | 1998-01-30 | 2007-06-06 | Darwin Discovery Ltd., Slough | N-hydroxyformamid-derivate |
| AU2001267468A1 (en) * | 2000-05-25 | 2001-12-03 | Smithkline Beecham P.L.C. | Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
-
2001
- 2001-11-27 GB GBGB0128376.1A patent/GB0128376D0/en not_active Ceased
-
2002
- 2002-11-25 DE DE60205035T patent/DE60205035T2/de not_active Expired - Fee Related
- 2002-11-25 AU AU2002365510A patent/AU2002365510A1/en not_active Abandoned
- 2002-11-25 AR ARP020104525A patent/AR037426A1/es not_active Application Discontinuation
- 2002-11-25 ES ES02790435T patent/ES2243783T3/es not_active Expired - Lifetime
- 2002-11-25 EP EP02790435A patent/EP1448529B1/en not_active Expired - Lifetime
- 2002-11-25 US US10/496,159 patent/US7038055B2/en not_active Expired - Fee Related
- 2002-11-25 JP JP2003547374A patent/JP2005513034A/ja active Pending
- 2002-11-25 AT AT02790435T patent/ATE299497T1/de not_active IP Right Cessation
- 2002-11-25 WO PCT/EP2002/013263 patent/WO2003045922A1/en not_active Ceased
- 2002-11-25 TW TW091134148A patent/TW200303746A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003045922A1 (en) | 2003-06-05 |
| ES2243783T3 (es) | 2005-12-01 |
| EP1448529A1 (en) | 2004-08-25 |
| DE60205035D1 (de) | 2005-08-18 |
| DE60205035T2 (de) | 2005-12-29 |
| JP2005513034A (ja) | 2005-05-12 |
| US7038055B2 (en) | 2006-05-02 |
| TW200303746A (en) | 2003-09-16 |
| US20050070572A1 (en) | 2005-03-31 |
| AR037426A1 (es) | 2004-11-10 |
| EP1448529B1 (en) | 2005-07-13 |
| AU2002365510A1 (en) | 2003-06-10 |
| GB0128376D0 (en) | 2002-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60224163D1 (de) | Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen | |
| DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
| ATE494279T1 (de) | Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate | |
| ATE369133T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| DE602004010407D1 (de) | Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden | |
| ATE542801T1 (de) | Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| ATE286028T1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
| DE602004022061D1 (de) | Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen | |
| DE60327622D1 (de) | Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien | |
| EP1701664A4 (en) | SYSTEM AND METHOD FOR PROCESSING A FABRIC | |
| FIU20060389U0 (fi) | Luusairauksien hoito | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60236743D1 (de) | Zur behandlung androgenabhängiger krankheiten | |
| ATE423099T1 (de) | Zur behandlung von schmerzen geeignete piperazine | |
| DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
| DE60233740D1 (de) | Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit | |
| DE60224004D1 (de) | Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten | |
| DE60223707D1 (de) | Calcium-l-threonat zur behandlung von knochenfrakturen | |
| DE60203878D1 (de) | Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen | |
| DE50313329D1 (de) | 1-phenyl-2-dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz | |
| EP1330271A4 (en) | USE OF TRANSCRIPTION FACTORS FOR THE TREATMENT OF INFLAMMATION AND OTHER DISEASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |